View Older Stories View More Recent Stories

Oct 27, 2022 04:31PM Form SC 13G IDEAYA Biosciences, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Oct 27, 2022 04:31PM Form SC 13D/A Gemini Therapeutics, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Oct 11, 2022 04:32PM Form SC 13D Gemini Therapeutics, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Oct 10, 2022 07:02AM Immunic Inc. (IMUX) Announces Oversubscribed $50M Private Placement at $4.35/sh
Oct 10, 2022 07:00AM Immunic, Inc. Announces $60.0 Million Oversubscribed Private Placement Equity Financing
Sep 30, 2022 04:31PM Form SC 13G ADAMS NATURAL RESOURCES Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Sep 19, 2022 08:00AM Ventyx Biosciences (VTYX) Announces $176.6 Million Private Placement of Common Stock
Sep 19, 2022 08:00AM Ventyx Biosciences Announces $176.6 Million Private Placement of Common Stock
Sep 16, 2022 04:05PM Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement
Sep 7, 2022 08:00AM TYME Technologies, Inc. Announces Proxy Advisory Firms Glass Lewis and ISS Recommend Stockholders Vote “FOR” Proposed Merger of Syros and Tyme
Aug 26, 2022 04:32PM Form SC 13G Provention Bio, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Aug 12, 2022 05:28PM Form SC 13G 89bio, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Aug 9, 2022 07:30AM Syros Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
Jul 27, 2022 04:16PM Form SC 13D East Resources Acquisiti Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Jul 18, 2022 04:31PM Form SC 13G Annexon, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Jul 18, 2022 04:31PM Form SC 13G NEWPARK RESOURCES INC Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Jul 11, 2022 06:25PM Annexon Closes $130 Million Private Placement Extending its Operating Runway into the Second Half of 2025
Jul 11, 2022 06:25PM Annexon Closes $130 Million Private Placement Extending its Operating Runway into the Second Half of 2025
Jul 8, 2022 04:31PM Form SC 13G SK Growth Opportunities Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Jul 8, 2022 07:00AM Annexon (ANNX) Announces $130 Million Private Placement Financing
Jul 8, 2022 07:00AM Annexon Announces $130 Million Private Placement Financing
Jul 8, 2022 07:00AM Annexon Announces $130 Million Private Placement Financing
Jul 5, 2022 07:02AM Syros Pharmaceuticals (SYRS) to Raise Approximately $190 Million Through Merger with TYME Technologies (TYME) and Concurrent Private Placement
Jul 5, 2022 07:00AM Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
Jun 27, 2022 04:31PM Form SC 13G Rezolute, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Jun 8, 2022 03:00AM ImaginAb and Roche have entered a clinical trial supply agreement for provision of atezolizumab (Tecentriq®)1 to Non-Small Cell Lung Cancer Patients Enrolled in ImaginAb's iPREDICT Phase IIb Study
Jun 3, 2022 04:24PM Imaging Endpoints (IE) and ImaginAb Inc Expand Partnership - IE to Supply Clinical Doses of CD8 Imaging Agent to BioPharma Companies
May 27, 2022 04:48PM Form SC 13G ArcLight Clean Transitio Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
May 24, 2022 03:00AM ImaginAb and [Yantai] DongCheng Pharmaceutical Group Sign Exclusive License Agreement to Commercialize CD8 ImmunoPET Agent in China to Serve Pharma and Healthcare Community
May 23, 2022 04:33PM Form SC 13G Investcorp India Acquisi Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
May 16, 2022 09:12AM Form 13F-HR ADAGE CAPITAL PARTNERS For: Mar 31
May 12, 2022 04:32PM Form SC 13G Chenghe Acquisition Co. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
May 12, 2022 04:05PM Rezolute Reports Third Quarter Fiscal 2022 Financial Results and Highlights Company Progress
May 12, 2022 04:05PM Rezolute Reports Third Quarter Fiscal 2022 Financial Results and Highlights Company Progress
May 12, 2022 03:00AM ImaginAb announces a new supply agreement with Invicro to offer clinical doses of CD8 investigational ImmunoPET imaging agent for Immuno-Oncology preclinical and clinical studies
May 5, 2022 03:00AM ImaginAb Announces New Supply Agreement to Supply Genmab A/S with its investigational CD8 ImmunoPET agent
May 4, 2022 09:33AM Rezolute, Inc. Announces Closing of Registered Direct Offering
May 4, 2022 09:33AM Rezolute, Inc. Announces Closing of Registered Direct Offering
May 2, 2022 04:30PM Form SC 13G Eiger BioPharmaceuticals Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Apr 26, 2022 09:05AM Harness Valuation Soars to $3.7 Billion With $230 Million in Series D Funding
Apr 21, 2022 04:31PM Form SC 13G MAMMOTH ENERGY SERVICES, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Apr 4, 2022 04:31PM Form SC 13G ImmunoGen, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Mar 24, 2022 04:32PM Form SC 13G Patria Latin American Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Mar 18, 2022 04:30PM Form SC 13G Patria Investments Ltd Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Mar 14, 2022 04:32PM Form SC 13G Sound Point Acquisition Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Mar 14, 2022 04:31PM Form SC 13G SHUAA Partners Acquisiti Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Mar 10, 2022 04:32PM Form SC 13G Fulcrum Therapeutics, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Mar 9, 2022 06:00AM Menlo Micro Announces $150 Million in Series C Funding as Ideal Switch™ Technology Accelerates the Electrification of Everything
Mar 7, 2022 05:01PM Form SC 13G PowerUp Acquisition Corp Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Mar 7, 2022 05:00PM Form SC 13G Falcon Minerals Corp Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
View More Recent Stories View Older Stories